174 related articles for article (PubMed ID: 26015459)
1. Patients and Physicians Can Discuss Costs of Cancer Treatment in the Clinic.
Kelly RJ; Forde PM; Elnahal SM; Forastiere AA; Rosner GL; Smith TJ
J Oncol Pract; 2015 Jul; 11(4):308-12. PubMed ID: 26015459
[TBL] [Abstract][Full Text] [Related]
2. Discussing Health Care Expenses in the Oncology Clinic: Analysis of Cost Conversations in Outpatient Encounters.
Hunter WG; Zafar SY; Hesson A; Davis JK; Kirby C; Barnett JA; Ubel PA
J Oncol Pract; 2017 Nov; 13(11):e944-e956. PubMed ID: 28834684
[TBL] [Abstract][Full Text] [Related]
3. The utility of cost discussions between patients with cancer and oncologists.
Zafar SY; Chino F; Ubel PA; Rushing C; Samsa G; Altomare I; Nicolla J; Schrag D; Tulsky JA; Abernethy AP; Peppercorn JM
Am J Manag Care; 2015 Sep; 21(9):607-15. PubMed ID: 26618364
[TBL] [Abstract][Full Text] [Related]
4. Medical oncologists' views on communicating with patients about chemotherapy costs: a pilot survey.
Schrag D; Hanger M
J Clin Oncol; 2007 Jan; 25(2):233-7. PubMed ID: 17210946
[TBL] [Abstract][Full Text] [Related]
5. Cost of Disease Progression in Patients with Metastatic Breast, Lung, and Colorectal Cancer.
Reyes C; Engel-Nitz NM; DaCosta Byfield S; Ravelo A; Ogale S; Bancroft T; Anderson A; Chen M; Matasar M
Oncologist; 2019 Sep; 24(9):1209-1218. PubMed ID: 30796156
[TBL] [Abstract][Full Text] [Related]
6. Does reimbursement influence chemotherapy treatment for cancer patients?
Jacobson M; O'Malley AJ; Earle CC; Pakes J; Gaccione P; Newhouse JP
Health Aff (Millwood); 2006; 25(2):437-43. PubMed ID: 16522584
[TBL] [Abstract][Full Text] [Related]
7. Continental Divide? The attitudes of US and Canadian oncologists on the costs, cost-effectiveness, and health policies associated with new cancer drugs.
Berry SR; Bell CM; Ubel PA; Evans WK; Nadler E; Strevel EL; Neumann PJ
J Clin Oncol; 2010 Sep; 28(27):4149-53. PubMed ID: 20697077
[TBL] [Abstract][Full Text] [Related]
8. Understanding patients' attitudes toward communication about the cost of cancer care.
Bullock AJ; Hofstatter EW; Yushak ML; Buss MK
J Oncol Pract; 2012 Jul; 8(4):e50-8. PubMed ID: 23180999
[TBL] [Abstract][Full Text] [Related]
9. Documenting the benefits and cost savings of a large multistate cancer pathway program from a payer's perspective.
Kreys ED; Koeller JM
J Oncol Pract; 2013 Sep; 9(5):e241-7. PubMed ID: 23943896
[TBL] [Abstract][Full Text] [Related]
10. Service setting impact on costs for bevacizumab-treated oncology patients.
Engel-Nitz NM; Yu EB; Becker LK; Small A
Am J Manag Care; 2014 Nov; 20(11):e515-22. PubMed ID: 25730350
[TBL] [Abstract][Full Text] [Related]
11. A review of cost communication in oncology: Patient attitude, provider acceptance, and outcome assessment.
Shih YT; Chien CR
Cancer; 2017 May; 123(6):928-939. PubMed ID: 27893929
[TBL] [Abstract][Full Text] [Related]
12. Willingness to pay to prevent chemotherapy induced nausea and vomiting among patients with breast, lung, or colorectal cancer.
Miller PJ; Balu S; Buchner D; Walker MS; Stepanski EJ; Schwartzberg LS
J Med Econ; 2013 Oct; 16(10):1179-89. PubMed ID: 23919632
[TBL] [Abstract][Full Text] [Related]
13. Physician Experience and Attitudes Toward Addressing the Cost of Cancer Care.
Altomare I; Irwin B; Zafar SY; Houck K; Maloney B; Greenup R; Peppercorn J
J Oncol Pract; 2016 Mar; 12(3):e281-8, 247-8. PubMed ID: 26883407
[TBL] [Abstract][Full Text] [Related]
14. How are you feeling? Who wants to know? Patients' and oncologists' preferences for discussing health-related quality-of-life issues.
Detmar SB; Aaronson NK; Wever LD; Muller M; Schornagel JH
J Clin Oncol; 2000 Sep; 18(18):3295-301. PubMed ID: 10986063
[TBL] [Abstract][Full Text] [Related]
15. Patient experience and attitudes toward addressing the cost of breast cancer care.
Irwin B; Kimmick G; Altomare I; Marcom PK; Houck K; Zafar SY; Peppercorn J
Oncologist; 2014 Nov; 19(11):1135-40. PubMed ID: 25273078
[TBL] [Abstract][Full Text] [Related]
16. [[How to finance chemotherapy with new cancer drugs?].
Livartowski A; Beuzeboc P; Le Vu B; Courbard M; Pierga JY; Extra JM; Scholl S; Pouillart P
Bull Cancer; 2000 Oct; 87(10):745-54. PubMed ID: 11084538
[TBL] [Abstract][Full Text] [Related]
17. American Society of Clinical Oncology guidance statement: the cost of cancer care.
Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy administration: modelling the costs of alternative protocols.
Haywood P; de Raad J; van Gool K; Haas M; Gallego G; Pearson SA; Faedo M; Ward R
Pharmacoeconomics; 2012 Dec; 30(12):1173-86. PubMed ID: 23148697
[TBL] [Abstract][Full Text] [Related]
19. Dose rounding of chemotherapy in colorectal cancer: an analysis of clinician attitudes and the potential impact on treatment costs.
Field K; Zelenko A; Kosmider S; Court K; Ng LL; Hibbert M; Gibbs P
Asia Pac J Clin Oncol; 2010 Sep; 6(3):203-9. PubMed ID: 20887502
[TBL] [Abstract][Full Text] [Related]
20. Treatment of lung cancer: will financial issues become a criterion of choice?
Vergnenegre A; Borget I; Chouaid C
Expert Rev Pharmacoecon Outcomes Res; 2013 Jun; 13(3):273-5. PubMed ID: 23763524
[No Abstract] [Full Text] [Related]
[Next] [New Search]
